Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination antifungal therapy

Thomas F Patterson1

  • 1University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.

The Pediatric Infectious Disease Journal
|June 12, 2003
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustained Reduction in Cardiopulmonary Fitness in Long COVID: A Report from the RECOVER-adult Cohort Study.

JACC. Advances·2026
Same author

Erratum for Wiederhold et al., "The next-generation polyene EL219 is efficacious in an experimental model of central nervous system coccidioidomycosis caused by <i>Coccidioides immitis</i>".

Antimicrobial agents and chemotherapy·2026
Same author

The novel second-generation triterpenoid SCY-247 maintains <i>in vitro</i> and <i>in vivo</i> activity against resistant <i>Candida glabrata</i>.

Antimicrobial agents and chemotherapy·2026
Same author

The next-generation polyene EL219 is efficacious in an experimental model of central nervous system coccidioidomycosis caused by <i>Coccidioides immitis</i>.

Antimicrobial agents and chemotherapy·2026
Same author

Long COVID trajectories in the prospectively followed RECOVER-Adult US cohort.

Nature communications·2025
Same author

Evaluation of Interventions for Cognitive Symptoms in Long COVID: A Randomized Clinical Trial.

JAMA neurology·2025
Same journal

Phase 2/3, Open-label, Randomized, Active-controlled Clinical Trial Evaluating the Safety and Efficacy of Imipenem/Cilastatin/Relebactam in Pediatric Patients From Birth to Less Than 18 Years With Gram-negative Bacterial Infections.

The Pediatric infectious disease journal·2026
Same journal

Determinants of Severity in Pediatric Viral Lower Respiratory Tract Diseases From Emergency Department Presentation to Hospital Course.

The Pediatric infectious disease journal·2026
Same journal

Oropharyngeal Colonization by Kingella kingae and Septic Arthritis in Children 6-48 Months of Age: A Portuguese Multicenter Case-control Study.

The Pediatric infectious disease journal·2026
Same journal

Trends in Late-onset Sepsis in Very Low Birth Weight Preterm Infants in the Brazilian Network on Neonatal Research: A 10-year Cohort Study.

The Pediatric infectious disease journal·2026
Same journal

Severe Mycoplasma-induced Rash and Mucositis Mimicking Stevens-Johnson Syndrome Treated With Steroid Pulse Therapy: A Case Highlighting Diagnostic Challenges and Therapeutic Considerations.

The Pediatric infectious disease journal·2026
Same journal

Clindamycin Prophylaxis in Pediatric Punctate Outer Retinal Toxoplasmosis.

The Pediatric infectious disease journal·2026
See all related articles